Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buttyan

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Toxicology and Applied Pharmacology|October 1, 1994
Apoptosis: molecular control point in toxicityG B Corcoran, L Fix, D P Jones, et al.
Endocrinology|March 31, 1999
Early effects of castration on the vascular system of the rat ventral prostate glandA Shabisgh, N Tanji, V D'Agati, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Bladder function in experimental outlet obstruction: pharmacologic responses to alterations in innervation, energetics, calcium mobilization, and geneticsR M Levin, N Haugaard, S S Levin, et al.
The Prostate|June 15, 1997
Abnormal prostate development in C3(1)-bcl-2 transgenic miceX Zhang, M W Chen, A Ng, et al.
The Prostate|May 8, 2000
Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castrationM Burchardt, T Burchardt, M W Chen, et al.
The Urologic Clinics of North America|May 1, 1995
Genetic and cellular characteristics of bladder outlet obstructionR M Levin, F C Monson, N Haugaard, et al.
Urology|June 1, 1996
Molecular staging of genitourinary malignanciesA E Katz, G M De Vries, C A Olsson, et al.
British Journal of Urology|March 1, 1996
The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancerC A Olsson, G M De Vries, M C Benson, et al.
The Prostate|September 6, 2001
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cellsM Burchardt, T Burchardt, A Shabsigh, et al.
The American Journal of Pathology|August 1, 1993
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancersM Colombel, F Symmans, S Gil, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Toxicology and Applied Pharmacology|October 1, 1994
Apoptosis: molecular control point in toxicityG B Corcoran, L Fix, D P Jones, et al.
Endocrinology|March 31, 1999
Early effects of castration on the vascular system of the rat ventral prostate glandA Shabisgh, N Tanji, V D'Agati, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Bladder function in experimental outlet obstruction: pharmacologic responses to alterations in innervation, energetics, calcium mobilization, and geneticsR M Levin, N Haugaard, S S Levin, et al.
The Prostate|June 15, 1997
Abnormal prostate development in C3(1)-bcl-2 transgenic miceX Zhang, M W Chen, A Ng, et al.
The Prostate|May 8, 2000
Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castrationM Burchardt, T Burchardt, M W Chen, et al.
The Urologic Clinics of North America|May 1, 1995
Genetic and cellular characteristics of bladder outlet obstructionR M Levin, F C Monson, N Haugaard, et al.
Urology|June 1, 1996
Molecular staging of genitourinary malignanciesA E Katz, G M De Vries, C A Olsson, et al.
British Journal of Urology|March 1, 1996
The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancerC A Olsson, G M De Vries, M C Benson, et al.
The Prostate|September 6, 2001
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cellsM Burchardt, T Burchardt, A Shabsigh, et al.
The American Journal of Pathology|August 1, 1993
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancersM Colombel, F Symmans, S Gil, et al.
Pageof 12